Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2

NCT06264479 is registered in ClinicalTrials.gov with Ourotech, Inc. as lead sponsor.

NCT NCT06264479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
Lead sponsor
Ourotech, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 19, 2024
Completion date
July 25, 2025
Enrollment
7 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, renal cell cancer metastatic